No Data
No Data
MannKind Corporation's (NASDAQ:MNKD) Institutional Investors Lost 3.9% Last Week but Have Benefitted From Longer-term Gains
Insider Sale: Director at $MNKD (MNKD) Sells 67,536 Shares
Tudor Pickering Holt Downgrades MannKind to Hold From Buy, Adjusts Price Target to $5.50 From $7
Oppenheimer Maintains MannKind(MNKD.US) With Buy Rating, Maintains Target Price $12
IntegriChain Revenue Optimization Experts to Speak at Informa's Pharma/BioTech GTN Summit
MannKind's Growth Momentum and Increased Confidence in Pipeline Elevate Buy Rating
loading...
Unlock the Full List
I Am 102927471 :